Gemayel Georges
- SEC CIK
- 0001256088
In the past year, 1 open-market sale filing worth $1.00M and no purchases.
Current role at each company
- IRON Disc Medicine, Inc.Directoras of Jun 23, 2026
- SUPN Supernus Pharmaceuticals, Inc.Directoras of Mar 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.00M
- 1 filing
- Net
- −$1.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gemayel Georges as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SUPN Supernus Pharmaceuticals, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 (view filing) | Sep 13 | 4 days | Gemayel GeorgesDirector | SSale | −13.9K | $31.33 | −$435.0K | −51.0%13.3K after | 2 lots |
| Nov 8, 2024 (view filing) | Nov 7 | 1 day | Gemayel GeorgesDirector | SSale | −14.2K | $36.62 | −$520.5K | −51.6%13.3K after | |
| Nov 12, 2024 (view filing) | Nov 8 | 4 days | Gemayel GeorgesDirector | SSale | −10.8K | $36.30 | −$391.6K | −44.8%13.3K after | |
| Mar 9, 2026 (view filing) | Mar 5-6 | 4 days | Gemayel GeorgesDirector | SSale | −18.8K | $53.38 | −$1.00M | −40.8%27.3K after | 2 lots |